DRW Securities’s Aurinia Pharmaceuticals AUPH Stock Holding History

DRW Securities’s Portfolio AUPH Stock Details AUPH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$378K	Buy	+22,294	New	+$356K	0.01%	502
2025 Q3	–	Sell	-27,009	Closed	-$229K	–	1287
2025 Q2	$229K	Buy	+27,009	New	+$217K	0.01%	889
2023 Q4	–	Sell	-25,050	Closed	-$195K	–	326
2023 Q3	$195K	Hold	25,050	–	–	﹤0.01%	314
2023 Q2	$242K	Sell	25,050 -18,902	-43%	-$196K	0.01%	283
2023 Q1	$482K	Buy	+43,952	New	+$387K	0.01%	207
2018 Q3	–	Sell	-31,300	Closed	-$176K	–	51
2018 Q2	$176K	Hold	31,300	–	–	0.01%	76
2018 Q1	$162K	Buy	+31,300	New	+$167K	0.01%	131

Other funds holding AUPH

TCM

Tang Capital Management San Diego, California $2.2B AUM 156.35% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

NMC

NEA Management Company Timonium, Maryland $1.59B AUM 234.06% 1-Year Est. Return

Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

DRW Securities's AUPH Position: Q2 2026 in Review

DRW Securities opened a new position in Aurinia Pharmaceuticals (AUPH) in Q2 2026: 22,294 shares worth $378K. The stake represents 0.01% of the portfolio and ranks #502 among its holdings. This is a return to the name: DRW Securities previously reported a position in AUPH as recently as Q2 2025.

DRW Securities first reported a position in AUPH in Q1 2018 and has held it in 7 quarters since. The position peaked at $482K in Q1 2023. 283 funds tracked by Wall St. Rank hold AUPH as of Q2 2026.

DRW Securities held 22,294 shares of Aurinia Pharmaceuticals worth $378K as of Q2 2026.
Aurinia Pharmaceuticals was a new DRW Securities position in Q2 2026.
Aurinia Pharmaceuticals made up 0.01% of DRW Securities's portfolio in Q2 2026, its #502 holding.
DRW Securities first reported a position in Aurinia Pharmaceuticals in Q1 2018 and has held it in 7 quarters since.
DRW Securities's Aurinia Pharmaceuticals position peaked at $482K in Q1 2023.
283 funds tracked by Wall St. Rank held Aurinia Pharmaceuticals as of Q2 2026.

Based on DRW Securities's 13F filing for Q2 2026, filed 14 Aug 2026.